Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer.
Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer. — المؤلف: Lee, Yong Jae — Cancer medicine 20200326
- المؤلف
- Lee, Yong Jae
- النشر
- Cancer medicine 20200326
- الوصف
- 564-571 p.
- الموضوعات
- Adult؛ Aged؛ Aged, 80 and over؛ Biomarkers؛ Chemotherapy, Adjuvant؛ Cytoreduction Surgical Procedures؛ Female؛ Humans